- Home
- MLAB vs ORC Comparison
MLAB vs ORC Comparison
Compare MLAB & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- ORC
- Stock Information
- Founded
- MLAB 1982
- ORC 2010
- Country
- MLAB United States
- ORC United States
- Employees
- MLAB N/A
- ORC N/A
- Industry
- MLAB Industrial Machinery/Components
- ORC Real Estate Investment Trusts
- Sector
- MLAB Industrials
- ORC Real Estate
- Exchange
- MLAB Nasdaq
- ORC Nasdaq
- Market Cap
- MLAB 692.9M
- ORC 623.6M
- IPO Year
- MLAB N/A
- ORC 2013
- Fundamental
- Price
- MLAB $139.61
- ORC $8.02
- Analyst Decision
- MLAB Hold
- ORC Buy
- Analyst Count
- MLAB 2
- ORC 2
- Target Price
- MLAB $140.00
- ORC $9.50
- AVG Volume (30 Days)
- MLAB 38.7K
- ORC 2.6M
- Earning Date
- MLAB 02-03-2025
- ORC 01-30-2025
- Dividend Yield
- MLAB 0.46%
- ORC 17.98%
- EPS Growth
- MLAB N/A
- ORC N/A
- EPS
- MLAB N/A
- ORC 1.01
- Revenue
- MLAB $228,380,000.00
- ORC $75,695,000.00
- Revenue This Year
- MLAB $11.32
- ORC N/A
- Revenue Next Year
- MLAB $5.98
- ORC N/A
- P/E Ratio
- MLAB N/A
- ORC $7.92
- Revenue Growth
- MLAB 6.88
- ORC N/A
- 52 Week Low
- MLAB $83.68
- ORC $7.41
- 52 Week High
- MLAB $147.34
- ORC $9.08
- Technical
- Relative Strength Index (RSI)
- MLAB 58.92
- ORC 58.47
- Support Level
- MLAB $131.90
- ORC $7.47
- Resistance Level
- MLAB $147.34
- ORC $8.03
- Average True Range (ATR)
- MLAB 5.52
- ORC 0.13
- MACD
- MLAB -0.41
- ORC 0.01
- Stochastic Oscillator
- MLAB 64.28
- ORC 95.61
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.